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Abstract: Vigorous restenosis is responsible for high failure rates of angioplasty in diabetic patients. Since
protein kinase C (PKC)β isoform activation is associated with vascular complications of diabetes, we have
determined whether PKCβ isoform overexpression can stimulate growth and migration of vascular smooth
muscle cells (SMCs) and cause an acceleration of arterial intimal hyperplasia. Overexpression of PKCβ1
(adv-PKCβ1) or β-galactosidase (adv-βgal) were achieved using replication-deficient adenovirus vectors in
cultured rat aortic SMCs and rat carotid arteries after balloon injury. Rat aortic SMCs infected with adv-
PKCβ1 at 10９ PFU／ml increased PKC activity and PKCβ1 isoform protein level by more than 10-fold com-
pared to adv-βgal infected SMCs at 4 days after infection. The growth and migration rates in PKCβ1 over-
expressed SMCs were increased by 1.5- to 1.9-fold compared to adv-βgal infected SMCs. Protein levels of
PKCβ1 isoform in adv-PKCβ1 infected arteries were increased by 4.2- and 2.0-fold compared to non-infected
and adv-βgal infected arteries, respectively, at 7 days after adenovirus infection. Ratio of intima／media area,
a marker of restenosis, were 0.26±0.08 and 0.54±0.14 (p<0.05) at 7 days after infection in adv-βgal and adv-
PKCβ1 infected arteries, respectively. Thus, overexpression of PKCβ isoform can enhance vascular SMCs
migration and growth, causing an accelerated rate of intimal hyperplasia, and may involve the restenotic
process after angioplasty in diabetic patients.
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Introduction
High failure rates in balloon angioplasty and
vascular grafts due to accelerated restenosis are
associated with cardiovascular morbidity and mor-
tality in diabetic patients３，１５，５１）. The development
of arterial restenosis could be due to arterial
smooth muscle cells (SMC) accumulation induced
by migration of SMC into the intima and its prolif-
eration. Although a great deal of studies have fo-
cused on the mechanism regarding the arterial
restenosis process, there have been relatively few
directed specificity at factors involved in the dia-
betic state４０，４１）.
One possible mechanism by which the resteno-
sis process can be accelerated in the diabetic state
is the activation of diacylglycerol (DAG)-protein
kinase C (PKC) pathway which has been demon-
strated to affect many vascular functions including
vascular SMC migration and growth and platelet
aggregation２９）. Recent studies have documented
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that hyperglycemia and diabetic condition will in-
crease DAG levels and PKC activities in the vas-
cular tissues of diabetic animals and patients. The
increases in PKC activity in diabetes are associ-
ated with retinal and renal hemodynamic changes,
cardiac dysfunctions and hypertrophy, cytokine
expression and angiogenesis２９）. PKC is a family of
serine-threonine kinases of at least twelve iso-
forms (α, β1, β2, γ, δ, ε, ζ, ν, η, θ, λ, µ) of varying
substrate preference, intracellular localization and
mode of activation６，３３，３５，３６，４４）. Among the different
PKC isoforms, hyperglycemia and diabetes are re-
ported to activate, preferentially, β-isoform in the
retina, heart, aorta and renal glomeruli２３，２５，２９）.
Functionally, using a PKCβ isoform selective in-
hibitor LY333531, the activation of PKCβ isoform
appears to be partly responsible for abnormalities
of retinal and renal blood flow, growth factors ex-
pression and extracellular matrix production２４）. In
addition, transgenic mice overexpressing PKCβ
isoform targeted specificity to the myocardium de-
veloped cardiac hypertrophy and dysfunction４６）.
However, a role of PKCβ isoform on the patho-
genesis of restenosis is still unclear.
In the present study, we have characterized the
effects of overexpressing PKCβ1 isoform both in
cultured cell and in vivo using adenoviral vectors
containing the full length cDNA of PKCβ1 isoform.
For in vivo studies, the effect of PKCβ1 overex-
pression on intimal hyperplasia after balloon in-
jury was studied, whereas the effect of PKCβ1 iso-
form on migration and growth of arterial SMCs
were also characterized.
Methods
Materials
Male Sprague-Dawley rats (body weight 350g)
were used for animal studies. Dulbecco's modified
Eagle medium (DMEM) and calf serum (CS) were
purchased from Gibco BRL (Grand Island, NY).
Anti-PKCβ1 antibody was obtained from Santa-
Cruz Biotech (Santa Cruz, CA). [γ-３２P]-ATP was
purchased from New England Nuclear (Boston,
MA). 293 cells were obtained from Microbix
(Toronto, Canada). Beta-gal staining kit was pur-
chased from Boehringer Mannheim (Indianapolis,
IL).
Construction of replication deficient adenovirus
containing PKC cDNA
Recombinant adenovirus containing full length
cDNA encoding PKCβ1 was generated as de-
scribed previously４，５）. Briefly, the mouse PKCβ1
cDNA obtained from Dr.P.Ashendal (Purdue Uni-
versity, IA) was ligated into the adenoviral shuttle
vector, pACCMVpLpA, downstream of the CMV-
promoter and upstream of a SV40 polyA tail sig-
nal. The resulting plasmid and pJM17, the E1A
transcription factor deficient adenoviral genomic
vector, were purified and co-transfected into E1A-
transformed 293 cells by calcium phosphate pre-
cipitation method. Subsequent generation of re-
combinant adenovirus expressing PKCβ1 (adv-
CMV-PKCβ1) in 293 cell lysates was confirmed by
Southern blot analysis. For the control, recombi-
nant adenovirus containing beta-galactosidase
(adv-βgal) was generated. The viruses were puri-
fied by cesium chloride gradient ultracentrifuga-
tion, desalted and then assayed for infectivity in a
293 cell plaque assay. Purified adenovirus stocks
were stored in 20% glycerol at －80℃.
Cell culture and in vitro infection with adenovirus
Primary rat aortic SMCs were obtained from
male Sprague-Dawley rats (100-150 g body weight)
by aortic media explant technique２２）. The cells
were grown in Dulbecco's modified Eagle medium
(DMEM) supplemented with 10% calf serum. The
cells were used within 10 passages for the various
experiments. After washing the subconfluent
SMCs with serum-free DMEM, adenovirus infec-
tion was performed by incubation with either adv-
βgal or adv-PKCβ1 at 1X10９ PFU／ml for one hour
at 37℃ as described４，５）. To determine the overex-
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pression of β-gal protein, cells were stained with β-
gal staining kit (Boehringer Manheim, Indianapolis,
IL). Cell viability was assessed by trypan blue ex-
clusion.
Intra-arterial administration of adenovirus in
balloon-injured rat carotid arteries
After rats were anesthetized with pentobarbital
sodium solution (Abbott Laboratories, North Chi-
cago, IL) at 1 mg／kg body weight, the left com-
mon carotid artery was isolated and injured with
2 Fr size Fogaty catheter (Baxter Healthcare Co.
Irvine, CA) as described previously１０，２７，３０，４５）. After
balloon injury, another catheter was introduced
into the lumen of the balloon injured arterial seg-
ments. The lumen of the artery was washed with
DMEM, 1x10９ PFU／ml of adenovirus solution was
instilled into the isolated arterial segments and in-
cubated for 15 minutes with the artery clamp dis-
tal to the injury site. After incubation, the carotid
artery was declamped and blood flow was re-
stored. At seven days after balloon injury with or
without adenoviral infection, rats were sacrificed
and the infected segments of common carotid ar-
tery were isolated for the various analysis.
Partial purification of PKC
Rat aortic SMCs and carotid arterial tissues
were washed with ice-cold phosphate buffered sa-
line (PBS). The carotid arterial tissues were frozen
in liquid nitrogen and crashed into frozen powder,
immediately. All samples were homogenized with
lysis buffer A, consisting of 20 mmol／l Tris-HCl,
pH 7.5, 2 mmol／l EDTA, 0.5 mmol／l sucrose and
leupeptin (1µg／ml) with polytron for 20 seconds
and with 60 strokes of a Dounce homogenizer.
The samples were centrifuged at 2,500 rpm for 10
minutes at 4℃. The cytosolic and membrane frac-
tions were fractionated with ultracentrifugation
method as described previously２２）. The resulting
supernatants were passed through 0.5 ml DEAE
column (Pharmacia, Uppsala, Sweden), washed
twice with 3 ml of buffer B (buffer A without su-
crose), and then finally eluted with 0.4 ml of buffer
B containing 200 mmol／l NaCl. Protein concentra-
tions of the samples were measured by Bradford's
method９）.
Assay of PKC activity
PKC activities were measured by their ability to
transfer ３２P from [γ-３２P] ATP into specific sub-
strate octapeptide (RKRTLRRL) in the presence of
Ca２＋ , phosphatidylserine , and diacylglycerol
(Avaiti , Pelham, AL) as described previ-
ously２０，３８，５０）. PKC activities were calculated by
subtracting the non-specific kinase activities ob-
tained in the absence of Ca２＋, phosphatidylserine,
or diacylglycerol.
Immunoblotting of PKCβ1
Partially purified PKC fractions from rat carotid
arteries or total cell lysate were separated on 8%
SDS-polyacrylamide gels under reducing condi-
tions and transferred to PDVF membranes
(Schleicher&Schuell, Keene, NH). Immunoblots
were incubated with anti-PKCβ1 isoform antibody
for 1 hour at room temperature. The blots were
washed and incubated with peroxidase-conjugated
anti-rabbit IgG. Specific bands were visualized by
ECL (Amersham, Arlington Heights, IL) and quan-
tified by a computing densitometer (Molecular Di-
namics, Sunnyvale, CA).
Morphometric analysis
The rat common carotid arteries were har-
vested at the described days after balloon injury
and adenoviral infection. The arteries were fixed
in 4% paraformaldehyde, embedded in paraffin,
sectioned to 5 µm, and stained with hematoxylin
and eosin to quantitate the neointimal hyperplasia.
The areas of intima, between the internal elastic
lamina to the luminal surface, and the medial layer
in each section were measured by using a micro-
scopical image analyzing system, AX-70 (Olympus,
Tokyo, Japan). Measurements of intima and medial
areas were made on three cross sections per rat
PKC β accelerates intimal hyperplasia
―４３―
taken from the middle of each carotid segment.
This analysis was performed by investigators
blinded to this experimental group.
Growth assay
Cultured rat aortic SMCs which were infected
with either adv-βgal or adv-PKCβ1 as described
above. After 2 days, cells were seeded in 24-well
plates at a density of 5,000 cells／well and cultured
with DMEM containing 1% calf serum for 24
hours. The cells were then stimulated with
DMEM containing 2%, 5% calf serum or 10 ng／ml
of PDGF-B chain, and cultured for three more
days. In another experiment, the infected rat aor-
tic SMCs were stimulated with DMEM containing
10% calf serum for 6 hours after cells were
seeded, and then cultured with DMEM containing
2% calf serum for 18 or 64 hours. Total cellular
DNA contents were measured using Hoechst-
33258 dye and a fluorometer (model TKO-100;
Hoefer Scientific Instruments, San Francisco, CA)
as described４９）.
Migration assay
Transwells which have polycarbonate mem-
branes with 8 µm pores (Corning Coster Co., Cam-
bridge, MA) were used for migration assay. These
membranes were coated with type I collagen (Vi-
trogen Collagen Co., Pleasanton, CA). Subconfluent
rat aortic SMCs infected with either adv-βgal or
adv-PKCβ1 were incubated with 0.1% bovine se-
rum albumin (BSA) in DMEM for 14 hours at 37 
Cells were washed three times in PBS and were
removed from the culture dish with trypsin for
the minimum period of time required to obtain a
monocellular suspension. Cells were washed twice
in DMEM with 0.1% BSA, and resuspended at a
density of 1x10５cells／ml. Conditioned media was
added into the lower wells and cell suspensions
were loaded to the top of the filter, and incubated
for 4 hours at 37℃ in 95% air/5% CO２. At the end
of the incubation time, the upper surface of tran-
swell was wiped completely to remove the cells,
and the cells on the bottom surface of transwell
were fixed with 70% ethanol and stained with SY-
TOX green nucleic acid stain (Molecular Probes,
Eugene, OR). Cells on the bottom side of the filter
were counted by using a video image processing
system.
Statistics
All results are expressed as mean±standard de-
viations. The unpaired Student's t test was used
for comparison of two groups. For experiments
containing more than two groups, comparisons
were made by ANOVA with Dunnett t test. Dif-
ferences are considered to be statistically signifi-
cant at the p<0.05.
Results
Time course of protein expression after adenovi-
rus infection
First, we examined the infectivity of adenovirus
to vascular SMCs and the time course of protein
overexpression in the cells after adenovirus infec-
tion. As shown in Fig. 1, percentage of the cells
positively stained with X-gal was reached 100% at
Fig.１． Time course of βgal protein expression
in rat aortic SMCs infected with adv-
βgal. The percentage of positively
stained cell number in one plate was
calculated. Results are expressed as
mean±SD derived from different four
experiments.
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4 days after infection with adenovirus (adv-βgal)
solution at 1x10９ PFU／ml for one hour. The PKCβ
1 isoform protein levels were increased by 2.5-,
18.0- and 8.0-fold at 1, 4 and 7 days after adenovi-
rus (adv-PKCβ1) infection at 1x10９ PFU／ml, re-
spectively (Fig. 2). All of these cells were still vi-
able (>98%) as assessed by trypan blue exclusion.
PKCβ1 isoform level and PKC activity after ade-
novirus infection in rat aortic SMCs
PKCβ1 isoform level in adv-PKCβ1 infected
SMCs was increased by more than ten fold com-
pared to non-infected SMCs and adv-βgal infected
SMCs at four days after adenovirus infection (Fig.
3A). PKC activity in adv－PKCβ1 infected SMCs
was increased by 17.0- and 12.2-fold in cytosolic
fraction, and by 4.4- and 5.8-fold in membrane frac-
tion compared to non-infected SMCs and adv-βgal
infected SMCs, respectively (Fig. 3B).
The effect of PKCβ1 isoform overexpression on
SMC growth
The effect of PKCβ1 isoform overexpression on
the proliferation and migration of rat aortic SMC
in vitro were investigated since these biological ac-
tions may have major roles in the restenotic proc-
ess. The growth rate of PKCβ1 overexpressed rat
aortic SMCs as measured by total DNA levels was
not changed compared to adv-βgal infected SMCs
at 6 hours after cells were seeded. But, at 24 and
72 hours after seeded, total DNA content was sig-
nificantly higher in PKCβ1 overexpressed SMCs
compared to adv-βgal infected SMCs (Fig. 4A).
There was no significant difference in growth rate
between non-infected SMCs and adv-βgal infected
SMCs.
Four days after seeding cells, the growth of
PKCβ1 overexpressed rat aortic SMCs as meas-
ured by total DNA levels was significantly in-
creased by 1.5- to 1.7-fold compared to adv-βgal in-
fected SMCs cultured with DMEM containing 2%,
5% calf serum or 10 ng／ml of PDGF-BB (Fig. 4B).
The effect of PKCβ1 isoform overexpression on
SMC migration
The migration of PKCβ1 overexpressed rat aor-
tic SMCs was significantly enhanced by 1.7-fold
compared to adv-βgal infected SMCs in the basal
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Fig.２． Time course of PKCβ1 isoform protein levels in rat aortic SMCs infected with adv-
PKCβ1. Upper panel shows immunoblots with anti-PKCβ1 antibody in rat aortic SMCs
at 0, 1, 4 and 7 days after adv-PKCβ1 infection. Lower panel shows densitometric quan-
tification of the immunoblot.
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Fig.３． PKCβ1 isoform protein level and PKC activity in rat aortic SMCs after adenovirus infection. (A). Im-
munoblots for PKCβ1 isoform in control, adv-βgal and adv-PKCβ1 infected rat aortic SMCs 4 days after
infection. (B). PKC activities in cytosolic and membrane fraction of control, adv-βgal and adv-PKCβ1 in-
fected rat aortic SMCs 4 days after infection. Results are presented as mean±SD derived from three
different experiments. ＊＊p<0.01 vs control, adv-βgal infected SMCs.
Ｂ．Ａ．
Fig.４． Growth of PKC overexpressed rat aortic SMCs. (A). Rat aortic SMCs which were infected with either
adv-βgal, adv-PKCβ1 or non-infected SMCs were seeded and cultured in 10% calf serum for 6 hours,
then cultured in 2% calf serum for appropriate time. DNA content was measured at 6, 24 and 72 hours
after seeded. Results are expressed as mean±SD derived from four different experiments. ＊p<0.05, ＊＊p
<0.01 vs adv-βgal infected SMCs and non-infected SMCs. ##p<0.01 vs 6 hours. (B). Rat aortic SMCs
were infected with either adv-βgal or adv-PKCβ1 were cultured in DMEM containing 1% calf serum for
one day and then cultured for 3 days in DMEM containing 2%, 5% calf serum or 10 ng/ml of PDGF-BB.
DNA content was measured at 4 days after seeding. Values are expressed as% of basal DNA contents,
and presented as mean±SD derived from four different experiments. ＊p<0.05, ＊＊p<0.01 vs adv-βgal in-
fected SMCs. #p<0.05, ##p<0.01 vs 2% calf serum.
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condition maintained with 0.1% BSA. Stimulation
with 1ng／ml PDGF-BB or 10% calf serum en-
hanced migration of βgal and PKCβ1 overex-
pressed aortic SMCs by 3.4-to 3.7-fold compared to
the basal. Moreover, migration of PKCβ1 overex-
presseed SMCs was significantly accelerated by
1.8-fold with 1 ng／ml PDGF-BB, and by 1.9-fold
with 10% calf serum compared to βgal infected
SMCs (Fig. 5).
PKCβ1 isoform overexpression in rat carotid ar-
tery
The potential role of PKCβ1 isoform on arterial
intimal hyperplasia was confirmed further by
overexpressing PKCβ1 isoform protein using adv-
PKCβ1 in balloon injured rat carotid arteries. Six-
teen rats were used for this experiment. As
shown in Fig. 6, PKCβ1 isoform protein levels
were significantly increased by 2.1-, 2.0- and 4.2-
fold in balloon injured (no adenoviral infection),
adv-βgal infected and adv-PKCβ1 infected arteries
compared to non-injured control arteries at 7 days
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Fig.５． Migration assay of PKCβ1 overex-
pressed rat aortic SMC and effects of 1
ng／ml of PDGF-BB or 10% calf serum.
Values are expressed as% of basal mi-
grating cell number and presented as
mean±SD derived from four different
experiments. ＊p<0.05, ＊＊p<0.01 vs adv-
βgal infected SMCs. #p<0.05, ##p<0.01
vs 0.1% BSA.
Fig.６． PKCβ1 isoform protein levels in balloon injured rat carotid arteries infected with adv-PKCβ1. Upper
panel shows immunoblots for PKCβ1 isoform in control non-injured carotid arteries, carotid arteries at
7 days after balloon injury without adenovirus infection or carotid arteries at 7 days after balloon in-
jury and infection with either adv-βgal or adv-PKCβ1. Lower panel shows densitometric quantification
of PKCβ1 isoform protein levels of carotid arteries. Results were shown as mean percentage of control
±SD (n=4). ＊p<0.05 vs balloon injured (no adenovirus infection) and adv-βgal infected arteries. #p<0.01
vs control arteries.
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after infection, respectively. And, significant in-
creases in total PKC activities of adv-PKCβ1 in-
fected arteries by 1.6-fold compared to adv-βgal in-
fected arteries were observed at 7 days after bal-
loon injury and adenovirus infection.
The effect of PKCβ1 isoform on intimal hyperpla-
sia
The biological effect of PKCβ1 isoform overex-
pression on neointimal formation was studied by
measuring the ratio of intimal area／medial area af-
ter balloon injury and infection with either adv-
βgal or adv-PKCβ1. Fourteen rats were used for
this experiment. Cross sections of carotid arteries
at 7 days after balloon injury and adenovirus in-
fection were shown in Fig. 7A. Histological exami-
nation demonstrated that neointimal thickening in
adv-PKCβ1 infected arteries were significantly
greater than adv-βgal infected arteries. The ratio
of intima／media of adv-PKCβ1 infected arteries
were quantitated as described in the method sec-
tion and found to be significantly increased by 2.1-
fold compared to adv-βgal infected arteries. No sig-
nificant differences were detected in medial area
between two groups (Fig. 7B).
Discussion
Present study demonstrated that overexpres-
sion of PKCβ1 isoform could enhance growth and
migration of vascular SMCs and that PKCβ1 over-
expression in rat carotid arteries after balloon in-
jury accelerated the rate of intimal hyperplasia.
To obtain the sufficient amount of PKCβ1 protein,
we used recombinant adenovirus vector for both
in vitro and in vivo studies. As shown in other
studies１３，１９）, using our adenovirus system, up to
Fig.７． (A). Cross sections of carotid arteries at 7 days after balloon injury and infection with either adv-βgal or
adv-PKCβ1 were stained with hematoxylin and eosin. Magnification of all sections; x100. (B). The ratio
of intima／media of carotid arteries at 7 days after balloon injury and infection with either adv-βgal or
adv-PKCβ1. Measurements of intima and medial areas were made on three cross sections per rat taken
from the middle of each carotid segment. Values are mean±SD (n=7). ＊p<0.05.
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98% of SMCs could be induced to express β-gal
protein 2 days after adenovirus infection as dem-
onstrated by β-gal staining, and protein levels
reached a maximum level 4 days after transfec-
tion. Previous paper has suggested that adenovi-
rus vectors, especially at higher titer, cause cell
damage and／or vascular inflammation, because of
the translation of viral open reading frame３４）. Our
data suggested that adenovirus vectors (adv-βgal
and adv-PKCβ1) at 10９ PFU／ml had no cytotoxic
effect as determined by trypan blue exclusion and
that adv-βgal overexpression had no effect on
PKCβ1 protein levels and PKC activities compared
to non-infected SMCs. Furthermore, attachment of
SMCs on culture dishes, which was determined by
the DNA content of the attached cells 6 hours af-
ter harvest by trypsinization, was not different be-
tween non-infected, adv-βgal and adv-PKCβ1 in-
fected SMCs. Nevertheless, growth rate of PKCβ1
overexpressed SMCs was significantly higher com-
pared to adv-βgal infected SMCs after 24 or 72
hours stimulation with serum or PDGF. It has
been shown that PKCβ1 isoform could stimulate
cell growth of R6 rat embryo fibroblast cell
line７，２１）, bovine aortic endotherial cells３９，４９）and bo-
vine arterial fibroblasts１２）. These are supportive
data for our present study which showed PKCβ1
isoform overexpression enhanced cell growth of
vascular SMCs. However, other reports demon-
strated that PKCβ isoform inhibited the growth of
colon cancer cell line１８） and keratinocyte cell
line３７）. Moreover, it has been reported that
PKCα４７）, and PKCδ１７） decreased growth rate of
vascular SMCs. These data indicates that the ef-
fect of PKCβ isoform on SMC growth could be cell
type-specific and isoform-specific. We showed here
that the ratio of intima／media area after balloon
injury was significantly increased in adv-PKCβ1
infected arteries with increased PKCβ1 isoform
protein level compared to adv-βgal infected arter-
ies in vivo. These data suggests that activation of
PKCβ isoform which is seen in diabetic condition
might involve in an acceleration of intimal hyper-
plasia after angioplasty.
In restenosis process, platelet deposition and re-
lease of growth factors, such as PDGF and bFGF,
have been postulated to be important for initiating
the cellular growth response after vascular in-
jury１，１１，３２，４２，４３，４８）. PDGF-B chain is known to acti-
vate mitogen-activated protein (MAP) kinases
and to be the most potent known chemoattractant
for vascular SMCs５２）. The signal transduction
pathways which mediate the chemotactic effects
of PDGF-BB on SMCs are still unknown, but sev-
eral classes of cellular components are implicated,
including focal adhesion kinase (p125FAK), small
GTP-binding protein of the rho family and certain
down-stream signaling of the PDGF beta receptor,
such as MAPK／ERK or PI3 kinase pathway１）.
PKC has been shown to regulate localization of cy-
toskeletal proteins and phosphorylation of FAK in-
duced by alpha v beta 5３１）. It has been established
that PKC plays a pivotal role in signal transduc-
tion pathways that influence numerous cellular
functions including cell proliferation and migra-
tion２６）. Several lines of evidence demonstrated that
classical type of PKC (α, β, γ), but not novel type of
PKC (δ, ζ, ε), are able to activate c-Raf, MEK／
MAPK pathway２，１４，１６，２８）. These findings suggest
that the activation of PKC could influence cellular
responses to PDGF or other growth factors in
restenosis process.
Among the various isoforms of PKC, PKCβ iso-
form appeared to be preferentially activated in
vascular tissues such as aorta and heart in dia-
betic rats８，４６）. Furthermore, it has been reported
that treatment of diabetic rats with PKCβ isoform
selective inhibitor could ameliorate several abnor-
malities in vascular functions２４）. These data sug-
gest that PKCβ isoform plays a pivotal role in the
pathogenesis of diabetic vascular complications.
However, specific substrate which is activated by
PKCβ, and leads to the activation of downstream
signal transduction pathways is still unknown.
Further studies will be needed.
In summary, the successful overexpression of
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―４９―
PKCβ1 isoform in cultured vascular SMCs and in
rat carotid arteries has clearly demonstrated that
PKCβ1 isoform overexpression can cause the ab-
normal migration and proliferation of vascular
SMC and lead to accelerated intimal hyperplasia
after balloon injury in rat carotid arteries. These
results suggest that PKCβ isoform may be pro-
posed as a new potential therapeutic target for
restenosis after angioplasty in diabetes.
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Protein Kinase C βの過剰発現は，バルーン傷害後の
ラット頸動脈の内膜肥厚を促進する
高原 秀典１），高原 典子２），George L.King３），
藤村 昌樹１）
１）滋賀医科大学第二外科
２）滋賀医科大学第三内科
３）Harvard Medical School, Joslin Diabetes Center
目 的
糖尿病では閉塞性動脈硬化性疾患に対する血行再
建後の再狭窄が高頻度に発生する．糖尿病の心血管
組織では protein kinase C β（PKCβ）が特異的に
活性化されており，心血管合併症の重要な要因と考
えられている．今回我々は，PKCβの過剰発現が血
管平滑筋細胞の増殖，遊走能および，バルーンによ
る血管傷害後の内膜肥厚に及ぼす影響について検討
した．
方 法
アデノウイルスベクターを用いて血管平滑筋細胞
に PKCβ1を過剰発現し，その増殖，遊走能を検討
した．また，ラット頸動脈を2Fr Fogaty バルーン
カテーテルを用いて内膜傷害した後，アデノウイル
スベクターにて血管壁に PKCβ1蛋白を過剰発現
し，７日後の内膜肥厚の変化を検討した．
結 果
PKCβ1を過剰発現した血管平滑筋細胞の PKCβ1
蛋白量及び PKC活性はコントロールウイルス（β-
galactosidase）を過剰発現したそれより１０倍以上増
加した．PKCβ1を過剰発現した血管平滑筋細胞の
増殖，遊走能は対照に比し，それぞれ１．５倍，１．９倍
の増加を認めた．傷害７日後のラット頸動脈のＰＫ
Ｃβ１蛋白量は，PKCβ1過剰発現群でバルーン未施
行群，β-gal 過剰発現群に対し，それぞれ４．２倍，２．０
倍に上昇した．７日後の intima／media 比は β-gal，
PKCβ1過剰発現群でそれぞれ０．２６±０．０８，０．５４±
０．１４であった．
考 察
PKCβの過剰発現は，血管平滑筋の増殖，遊走能
を亢進し，内膜傷害後の血管再狭窄を増悪する可能
性が示唆された．
PKC β accelerates intimal hyperplasia
―５３―
